Product Details
CE Blood Sugar Checking Machine , Diabetes Monitoring
Devices Support Alternate Site Testing
FAD-GDH System | |
Blood sample: | fresh capillary whole blood, venous whole blood |
Calibration sample: | venous plasma |
Test range: | 20-600mg/dL(1.1-33.3mmol/L) |
Test time: | 10s |
Blood volume: | 0.6ul |
HCT: | 30-60% |
Expiry date: | 24 months |
Memory: | 200test results |
Battery lifetime: | above 1000 times
|
Other Parameters:
1. Display screen: big LCD screen;
2. Power supply: 2*AAA battery
3. Battery lifetime: Above 1000 times
4. No coding, easy to use
5. Anti-interference
6.Automatic strips ajection
7. 0.6ul tiny blood sample
8. Light warning
9. Carry use
The biggest Blood Glucose Monitoring System production base in
Asia.
Sinocare has an excellent R&D team focusing on developing
top-ranking Blood Glucose Monitors and other diabetes care related
multi-analysis monitoring systems. Benefiting from AMM technology,
Sinocare R&D team is now exploring a Prevention and Treatment
Model (Monitoring-Evaluation-Intervention) to effectively manage
diabetes. With goals clearly in mind, Sinocare is now transferring
from “BGM Promoter of China” to“Diabetes Management Expert in
China”, and “global BGM Expert”
Company Profile
Sinocare is a high-tech enterprise dedicated to the development,
production and sales of the rapid detection of chronic diseases in
the use of bio sensing technology. Since its inception in 2002, has
been adhering to the business purpose “Honor Commitment Dedicate to
Healthcare", focus on promoting the development of diabetes health.
Sinocare is a high-tech enterprise dedicated to the development,
production and sales of the rapid detection of chronic diseases in
the use of bio sensing technology. Since its inception in 2002, has
been adhering to the business purpose “Honor Commitment Dedicate to
Healthcare", focus on promoting the development of diabetes health.
Sinocare as a national high-tech industrialization demonstration
project, has won National Innovation Fund support, and took the
lead through the ISO 13485 Quality Management System certification
and the CE certification of EU. The SANNUO series blood glucose
meter and a test strips, with the characteristics of the "accuracy,
simple and economic", recognized by the vast number of consumers,
the "Sinocare" trademark was identified as "China well known
trademark by State Administration of industry and Commerce of. The
products are not only popular in China, but also in the
international market. In March 19, 2012, the company listed on the
Shenzhen stock exchange gem, as the first Bio sensor stock in
China. In 2015, the blood glucose meter in the domestic retail
market share reached 51%, becoming the industry leader in blood
glucose monitoring products, the same year was elected to the
Forbes Asian small and medium companies top 200 list. In 2014
September,Sinocare acquired Beijing Jianheng Diabetes Hospital,to
step into health service area. In January of 2016, Sinocare
acquired Nipro diagnostic Inc. (now renamed as Trividia Health
Inc.), the world's sixth BGM enterprise, and reached the
international leading BGM corporation, In July of 2016, completed
acquisition of PTS Diagnostics, expand the POCT testing business,
to provide a more comprehensive solution for chronic disease
prevention.